Trials / Unknown
UnknownNCT04213287
Multimodal Analgesia Methods in Patients Undergoing IPACK Block in Knee Arthroplasty
Evaluation of Multimodal Analgesia Methods in Patients Who Underwent IPACK Block in Total Knee Arthroplasty
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Ankara Diskapi Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
A comparison of two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) - in patients undergoing total knee arthroplasty. dexketoprofen and paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).
Detailed description
Postoperative pain after total knee arthroplasty is serious and difficult to management. Multimodal analgesia recommended for the pain management. For these reasons, we planned a study involving two multimodal analgesia regimens. Patients who will undergo total knee arthroplasty will receive preemptive oral analgesic (dexketofrofen) 1 hour before the operation. Surgery will be initiated after spinal anesthesia is applied to the patients. Two pain control methods - the combination of Adductor Canal Block (ACB)/Infiltration of the interspace between the popliteal artery and the capsule of the posterior knee (IPACK) versus the Periarticular Injection (PAI)/ IPACK- will be applied at the end of the surgery. dexketoprofenand paracetamol will be added to both groups and multimodal analgesia will be applied. Primary outcome is NRS pain scores with ambulation on postoperative day one (24 hours post-block administration).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexketoprofen Trometamol | Drug: Dexketoprofen Trometamol oral tablet |
| OTHER | spinal anesthesia | Drug: heavy bupivacaine 2,5 ml 0,5% |
| OTHER | IPACK | Drug: bupivacaine 20 ml 0,025% |
| OTHER | PAI | Drug: bupivacaine 30 ml 0,025% |
| OTHER | Adductor canal block | Drug: bupivacaine 20 ml 0,025% |
Timeline
- Start date
- 2019-12-23
- Primary completion
- 2020-03-01
- Completion
- 2020-03-15
- First posted
- 2019-12-30
- Last updated
- 2019-12-30
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT04213287. Inclusion in this directory is not an endorsement.